6588Background: Data suggest that newly approved cancer drugs have worse safety and tolerability profiles than older drugs used as control groups in trials. However, less is known about the toxicit... Click to show full abstract
6588Background: Data suggest that newly approved cancer drugs have worse safety and tolerability profiles than older drugs used as control groups in trials. However, less is known about the toxicit...
               
Click one of the above tabs to view related content.